Bustamante P, Peña M A, Barra J
Department of Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
J Pharm Pharmacol. 1998 Sep;50(9):975-82. doi: 10.1111/j.2042-7158.1998.tb06911.x.
The expanded Hansen method was tested for determination of the solubility parameters of two non-steroidal anti-inflammatory drugs, naproxen and sodium diclofenac. This work describes for the first time the application of the method to the sodium salt of a drug. The original dependent variable of the expanded Hansen method, involving the activity coefficient of the drug, was compared with the direct use of the logarithm of the mole fraction solubility 1nX2 in the solubility models. The solubility of both drugs was measured in pure solvents of several chemical classes and the activity coefficient was obtained from the molar heat and the temperature of fusion. Differential scanning calorimetry was performed on the original powder and on the solid phase after equilibration with the pure solvents, enabling detection of possible changes of the thermal properties of the solid phase that might change the value of the activity coefficient. The molar heat and temperature of fusion of sodium diclofenac could not be determined because this drug decomposed near the fusion temperature. The best results for both drugs were obtained with the dependent variable 1nX2 in association with the four-parameter model which includes the acidic and basic partial-solubility parameters delta(a) and delta(b) instead of the Hansen hydrogen bonding parameter delta(h). Because the dispersion parameter does not vary greatly from one drug to another, the variation of solubility among solvents is largely a result of the dipolar and hydrogen-bonding parameters, a fact that is being consistently found for other drugs of small molecular weight. These results support earlier findings with citric acid and paracetamol that the expanded Hansen approach is suitable for determining partial-solubility parameters. The modification introduced in the expanded Hansen method, i.e. the use of 1nX2 as the dependent variable, provides better results than the activity coefficient used in the original method. This is advantageous for drugs such as sodium diclofenac for which the ideal solubility cannot be estimated. This paper shows for the first time that the method is suitable for determination of the partial-solubility parameters of a sodium salt of a drug, sodium diclofenac.
采用扩展的汉森方法测定了两种非甾体抗炎药萘普生和双氯芬酸钠的溶解度参数。这项工作首次描述了该方法在药物钠盐中的应用。将扩展汉森方法的原始因变量(涉及药物的活度系数)与在溶解度模型中直接使用摩尔分数溶解度的对数(lnX2)进行了比较。在几种化学类别的纯溶剂中测量了两种药物的溶解度,并从摩尔热和熔化温度获得了活度系数。对原始粉末以及与纯溶剂平衡后的固相进行了差示扫描量热法,从而能够检测可能改变活度系数值的固相热性质变化。双氯芬酸钠的摩尔热和熔化温度无法确定,因为该药物在熔化温度附近分解。两种药物使用因变量lnX2与包含酸性和碱性部分溶解度参数δ(a)和δ(b)而非汉森氢键参数δ(h)的四参数模型结合时,得到了最佳结果。由于色散参数在不同药物之间变化不大,溶剂间溶解度的变化在很大程度上是偶极和氢键参数的结果,这一事实在其他小分子药物中也一直被发现。这些结果支持了早期对柠檬酸和对乙酰氨基酚的研究结果,即扩展的汉森方法适用于确定部分溶解度参数。扩展汉森方法中引入的修改,即使用lnX2作为因变量,比原始方法中使用的活度系数提供了更好的结果。这对于无法估算理想溶解度的药物如双氯芬酸钠是有利的。本文首次表明该方法适用于测定药物双氯芬酸钠钠盐的部分溶解度参数。